TC-F2

Overview

TC-F2 is a reversible non-covalent binding inhibitor of fatty acid amide hydrolase ( FAAH ) with an IC 50 of 28 nM. FAAH is involved in many human diseases, particularly cancer , pain and inflammation as well as neurological, metabolic and cardiovascular disorders.

Application

Products | Products > Disease Areas > Pain | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FAAH

Product Information

• Catalog No.: HY-103462
• CAS No.: 1304778-15-1
• Molecular Formula: C26H25N5O2
• Molecular Weight: 439.51
• Purity: 99.35%
• Storage: -20°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: 2.08 mg/mL (4.73 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source